No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US ETFDetailed Quotes
PSIL ADVISORSHARES PSYCHEDELICS ETF
- 10.623
- +0.121+1.15%
Close Dec 20 16:00 ET
10.630High10.500Low
10.630High10.500Low3.66KVolume10.500Open10.503Pre Close38.66KTurnover0.65%Turnover Ratio--P/E (Static)564.98KShares16.76952wk High--P/B6.00MFloat Cap7.14052wk Low0.11Dividend TTM564.98KShs Float103.293Historical High1.03%Div YieldTTM1.24%Amplitude7.140Historical Low10.551Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
ADVISORSHARES PSYCHEDELICS ETF To Go Ex-Dividend On December 23rd, 2024 With 0.05477 USD Dividend Per Share
December 20th (Eastern Time) - $ADVISORSHARES PSYCHEDELICS ETF(PSIL.US)$ is trading ex-dividend on December 23rd, 2024.Shareholders of record on December 23rd, 2024 will receive 0.05477 USD dividend
Needham Reiterates Hold on Neurocrine Biosciencesto Hold
MindMed To Be Added To The Nasdaq Biotechnology Index, Effective At Market Open On December 23, 2024
As Small-caps Ride the Trump Wave, Here Are the Best & Worst Such Stocks as per SA Quant
Mind Medicine Analyst Ratings
Summit Therapeutics Shares Are Trading Higher. The Stock May Be Moving in Sympathy With Neurocrine Biosciences Which Received FDA Approval for CRESNESSITY.